nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—CYP1A2—Dacarbazine—sarcoma	0.11	0.282	CbGbCtD
Estropipate—CYP3A4—Thiotepa—sarcoma	0.104	0.266	CbGbCtD
Estropipate—CYP1A2—Etoposide—sarcoma	0.0537	0.138	CbGbCtD
Estropipate—CYP3A4—Mitoxantrone—sarcoma	0.0446	0.114	CbGbCtD
Estropipate—CYP3A4—Vincristine—sarcoma	0.0307	0.0788	CbGbCtD
Estropipate—CYP3A4—Etoposide—sarcoma	0.0281	0.0722	CbGbCtD
Estropipate—CYP3A4—Doxorubicin—sarcoma	0.0192	0.0492	CbGbCtD
Estropipate—ESR2—Validated nuclear estrogen receptor beta network—SMARCB1—sarcoma	0.0124	0.101	CbGpPWpGaD
Estropipate—SHBG—hindlimb—sarcoma	0.0111	0.12	CbGeAlD
Estropipate—ESR1—periosteum—sarcoma	0.011	0.119	CbGeAlD
Estropipate—SHBG—Nongenotropic Androgen signaling—PLCG1—sarcoma	0.00786	0.0643	CbGpPWpGaD
Estropipate—ESR2—Ovarian Infertility Genes—GJA4—sarcoma	0.00705	0.0577	CbGpPWpGaD
Estropipate—ESR2—mammary gland—sarcoma	0.00477	0.0515	CbGeAlD
Estropipate—SHBG—Nongenotropic Androgen signaling—CREB1—sarcoma	0.00404	0.0331	CbGpPWpGaD
Estropipate—ALB—mammary gland—sarcoma	0.00383	0.0414	CbGeAlD
Estropipate—ESR2—Validated nuclear estrogen receptor alpha network—COL18A1—sarcoma	0.00349	0.0286	CbGpPWpGaD
Estropipate—ESR1—mammary gland—sarcoma	0.00327	0.0353	CbGeAlD
Estropipate—ESR2—hematopoietic system—sarcoma	0.00291	0.0314	CbGeAlD
Estropipate—SHBG—hematopoietic system—sarcoma	0.00283	0.0305	CbGeAlD
Estropipate—ESR2—connective tissue—sarcoma	0.0028	0.0302	CbGeAlD
Estropipate—SHBG—connective tissue—sarcoma	0.00272	0.0294	CbGeAlD
Estropipate—ALB—Scavenging of heme from plasma—HBA1—sarcoma	0.00266	0.0217	CbGpPWpGaD
Estropipate—SHBG—Nongenotropic Androgen signaling—SRC—sarcoma	0.00261	0.0213	CbGpPWpGaD
Estropipate—ESR2—smooth muscle tissue—sarcoma	0.00256	0.0277	CbGeAlD
Estropipate—ESR1—LKB1 signaling events—EZR—sarcoma	0.0025	0.0205	CbGpPWpGaD
Estropipate—CYP2C9—mammary gland—sarcoma	0.00239	0.0258	CbGeAlD
Estropipate—ESR1—FOXA1 transcription factor network—COL18A1—sarcoma	0.00238	0.0195	CbGpPWpGaD
Estropipate—ESR1—myometrium—sarcoma	0.00232	0.025	CbGeAlD
Estropipate—ESR1—Signaling mediated by p38-alpha and p38-beta—MITF—sarcoma	0.00223	0.0183	CbGpPWpGaD
Estropipate—ESR1—embryo—sarcoma	0.00223	0.0241	CbGeAlD
Estropipate—ESR2—Plasma membrane estrogen receptor signaling—IGF1R—sarcoma	0.00222	0.0181	CbGpPWpGaD
Estropipate—ESR2—uterus—sarcoma	0.0022	0.0237	CbGeAlD
Estropipate—SHBG—uterus—sarcoma	0.00214	0.0231	CbGeAlD
Estropipate—ESR2—lymphoid tissue—sarcoma	0.00205	0.0221	CbGeAlD
Estropipate—ESR1—hematopoietic system—sarcoma	0.00199	0.0215	CbGeAlD
Estropipate—ESR1—connective tissue—sarcoma	0.00192	0.0207	CbGeAlD
Estropipate—SHBG—Nongenotropic Androgen signaling—HRAS—sarcoma	0.00184	0.015	CbGpPWpGaD
Estropipate—SHBG—bone marrow—sarcoma	0.00181	0.0196	CbGeAlD
Estropipate—ESR1—Validated nuclear estrogen receptor alpha network—COL18A1—sarcoma	0.00176	0.0144	CbGpPWpGaD
Estropipate—ESR1—smooth muscle tissue—sarcoma	0.00175	0.0189	CbGeAlD
Estropipate—ESR1—Signaling mediated by p38-alpha and p38-beta—ATF1—sarcoma	0.00162	0.0132	CbGpPWpGaD
Estropipate—ESR2—testis—sarcoma	0.00159	0.0172	CbGeAlD
Estropipate—SHBG—testis—sarcoma	0.00155	0.0167	CbGeAlD
Estropipate—CYP1A2—hematopoietic system—sarcoma	0.00154	0.0166	CbGeAlD
Estropipate—ESR2—liver—sarcoma	0.00151	0.0163	CbGeAlD
Estropipate—ESR1—uterus—sarcoma	0.0015	0.0162	CbGeAlD
Estropipate—SHBG—liver—sarcoma	0.00146	0.0158	CbGeAlD
Estropipate—CYP2C9—hematopoietic system—sarcoma	0.00146	0.0157	CbGeAlD
Estropipate—ESR2—Plasma membrane estrogen receptor signaling—MMP2—sarcoma	0.00142	0.0117	CbGpPWpGaD
Estropipate—ESR1—lymphoid tissue—sarcoma	0.0014	0.0151	CbGeAlD
Estropipate—ESR1—Estrogen Receptor Pathway—JUN—sarcoma	0.00139	0.0114	CbGpPWpGaD
Estropipate—ESR1—Regulation of Telomerase—WT1—sarcoma	0.00131	0.0107	CbGpPWpGaD
Estropipate—ALB—testis—sarcoma	0.00128	0.0138	CbGeAlD
Estropipate—SLC22A1—liver—sarcoma	0.00126	0.0136	CbGeAlD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—MYOD1—sarcoma	0.00123	0.0101	CbGpPWpGaD
Estropipate—ESR1—Estrogen signaling pathway—CREB1—sarcoma	0.00122	0.01	CbGpPWpGaD
Estropipate—ALB—liver—sarcoma	0.00121	0.0131	CbGeAlD
Estropipate—ESR2—lymph node—sarcoma	0.00116	0.0125	CbGeAlD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.00114	0.00933	CbGpPWpGaD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—sarcoma	0.00112	0.00914	CbGpPWpGaD
Estropipate—CYP3A4—hematopoietic system—sarcoma	0.00111	0.012	CbGeAlD
Estropipate—ESR1—testis—sarcoma	0.00109	0.0118	CbGeAlD
Estropipate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—HBA1—sarcoma	0.00106	0.00867	CbGpPWpGaD
Estropipate—ESR1—liver—sarcoma	0.00103	0.0111	CbGeAlD
Estropipate—ESR2—Plasma membrane estrogen receptor signaling—SRC—sarcoma	0.000986	0.00807	CbGpPWpGaD
Estropipate—ESR2—Plasma membrane estrogen receptor signaling—NRAS—sarcoma	0.000949	0.00777	CbGpPWpGaD
Estropipate—ALB—lymph node—sarcoma	0.000928	0.01	CbGeAlD
Estropipate—ESR1—Leptin signaling pathway—PLCG1—sarcoma	0.000924	0.00756	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—HBA1—sarcoma	0.00089	0.00728	CbGpPWpGaD
Estropipate—ESR1—Estrogen signaling pathway—JUN—sarcoma	0.000881	0.00721	CbGpPWpGaD
Estropipate—ESR1—Signaling mediated by p38-alpha and p38-beta—CREB1—sarcoma	0.000875	0.00716	CbGpPWpGaD
Estropipate—ESR2—Plasma membrane estrogen receptor signaling—KRAS—sarcoma	0.000817	0.00668	CbGpPWpGaD
Estropipate—Hepatic function abnormal—Doxorubicin—sarcoma	0.000808	0.00204	CcSEcCtD
Estropipate—Anaphylactic shock—Mitoxantrone—sarcoma	0.000804	0.00203	CcSEcCtD
Estropipate—Oedema—Mitoxantrone—sarcoma	0.000804	0.00203	CcSEcCtD
Estropipate—Gastrointestinal disorder—Thiotepa—sarcoma	0.000804	0.00203	CcSEcCtD
Estropipate—Fatigue—Thiotepa—sarcoma	0.000803	0.00203	CcSEcCtD
Estropipate—Infection—Mitoxantrone—sarcoma	0.000799	0.00202	CcSEcCtD
Estropipate—Dermatitis bullous—Epirubicin—sarcoma	0.000798	0.00202	CcSEcCtD
Estropipate—Fatigue—Dactinomycin—sarcoma	0.000797	0.00202	CcSEcCtD
Estropipate—Constipation—Thiotepa—sarcoma	0.000797	0.00201	CcSEcCtD
Estropipate—Pain—Thiotepa—sarcoma	0.000797	0.00201	CcSEcCtD
Estropipate—CYP1A2—liver—sarcoma	0.000796	0.00859	CbGeAlD
Estropipate—Back pain—Etoposide—sarcoma	0.000793	0.00201	CcSEcCtD
Estropipate—Purpura—Epirubicin—sarcoma	0.000792	0.002	CcSEcCtD
Estropipate—ESR1—lymph node—sarcoma	0.000791	0.00854	CbGeAlD
Estropipate—Pain—Dactinomycin—sarcoma	0.000791	0.002	CcSEcCtD
Estropipate—Anaphylactoid reaction—Epirubicin—sarcoma	0.000788	0.00199	CcSEcCtD
Estropipate—Muscle spasms—Etoposide—sarcoma	0.000788	0.00199	CcSEcCtD
Estropipate—Skin disorder—Mitoxantrone—sarcoma	0.000781	0.00198	CcSEcCtD
Estropipate—ESR1—ATF-2 transcription factor network—PDGFRA—sarcoma	0.000781	0.00639	CbGpPWpGaD
Estropipate—Cerebrovascular accident—Epirubicin—sarcoma	0.000779	0.00197	CcSEcCtD
Estropipate—ESR2—Validated nuclear estrogen receptor alpha network—CCND1—sarcoma	0.000772	0.00632	CbGpPWpGaD
Estropipate—ESR2—Validated nuclear estrogen receptor alpha network—JUN—sarcoma	0.00077	0.0063	CbGpPWpGaD
Estropipate—Pain in extremity—Epirubicin—sarcoma	0.000763	0.00193	CcSEcCtD
Estropipate—Gastrointestinal pain—Thiotepa—sarcoma	0.000762	0.00193	CcSEcCtD
Estropipate—Gastrointestinal pain—Dactinomycin—sarcoma	0.000756	0.00191	CcSEcCtD
Estropipate—CYP2C9—liver—sarcoma	0.000755	0.00815	CbGeAlD
Estropipate—Musculoskeletal discomfort—Vincristine—sarcoma	0.000753	0.0019	CcSEcCtD
Estropipate—Migraine—Epirubicin—sarcoma	0.000751	0.0019	CcSEcCtD
Estropipate—Insomnia—Vincristine—sarcoma	0.000747	0.00189	CcSEcCtD
Estropipate—ESR1—LKB1 signaling events—CREB1—sarcoma	0.000742	0.00607	CbGpPWpGaD
Estropipate—Paraesthesia—Vincristine—sarcoma	0.000742	0.00188	CcSEcCtD
Estropipate—Urticaria—Thiotepa—sarcoma	0.00074	0.00187	CcSEcCtD
Estropipate—Dermatitis bullous—Doxorubicin—sarcoma	0.000739	0.00187	CcSEcCtD
Estropipate—Vertigo—Etoposide—sarcoma	0.000737	0.00186	CcSEcCtD
Estropipate—Body temperature increased—Thiotepa—sarcoma	0.000736	0.00186	CcSEcCtD
Estropipate—Abdominal pain—Thiotepa—sarcoma	0.000736	0.00186	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000733	0.00185	CcSEcCtD
Estropipate—Purpura—Doxorubicin—sarcoma	0.000733	0.00185	CcSEcCtD
Estropipate—Abdominal pain—Dactinomycin—sarcoma	0.000731	0.00185	CcSEcCtD
Estropipate—Body temperature increased—Dactinomycin—sarcoma	0.000731	0.00185	CcSEcCtD
Estropipate—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00073	0.00185	CcSEcCtD
Estropipate—ALB—Folate Metabolism—HBA1—sarcoma	0.000724	0.00593	CbGpPWpGaD
Estropipate—Mood swings—Epirubicin—sarcoma	0.000723	0.00183	CcSEcCtD
Estropipate—Paraesthesia—Mitoxantrone—sarcoma	0.000722	0.00183	CcSEcCtD
Estropipate—Cerebrovascular accident—Doxorubicin—sarcoma	0.000721	0.00182	CcSEcCtD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—MMP2—sarcoma	0.000718	0.00587	CbGpPWpGaD
Estropipate—Cough—Etoposide—sarcoma	0.000715	0.00181	CcSEcCtD
Estropipate—Somnolence—Mitoxantrone—sarcoma	0.000715	0.00181	CcSEcCtD
Estropipate—Gastrointestinal disorder—Vincristine—sarcoma	0.000713	0.0018	CcSEcCtD
Estropipate—Fatigue—Vincristine—sarcoma	0.000712	0.0018	CcSEcCtD
Estropipate—Dyspepsia—Mitoxantrone—sarcoma	0.000708	0.00179	CcSEcCtD
Estropipate—Pain—Vincristine—sarcoma	0.000706	0.00179	CcSEcCtD
Estropipate—Constipation—Vincristine—sarcoma	0.000706	0.00179	CcSEcCtD
Estropipate—Pain in extremity—Doxorubicin—sarcoma	0.000706	0.00179	CcSEcCtD
Estropipate—ESR1—FOXM1 transcription factor network—MMP2—sarcoma	0.000704	0.00576	CbGpPWpGaD
Estropipate—Migraine—Doxorubicin—sarcoma	0.000695	0.00176	CcSEcCtD
Estropipate—ESR2—Plasma membrane estrogen receptor signaling—HRAS—sarcoma	0.000694	0.00568	CbGpPWpGaD
Estropipate—Fatigue—Mitoxantrone—sarcoma	0.000694	0.00175	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000693	0.00175	CcSEcCtD
Estropipate—Breast disorder—Epirubicin—sarcoma	0.00069	0.00174	CcSEcCtD
Estropipate—Constipation—Mitoxantrone—sarcoma	0.000688	0.00174	CcSEcCtD
Estropipate—Pain—Mitoxantrone—sarcoma	0.000688	0.00174	CcSEcCtD
Estropipate—Hypersensitivity—Thiotepa—sarcoma	0.000686	0.00174	CcSEcCtD
Estropipate—Hypersensitivity—Dactinomycin—sarcoma	0.000681	0.00172	CcSEcCtD
Estropipate—Gastrointestinal pain—Vincristine—sarcoma	0.000675	0.00171	CcSEcCtD
Estropipate—ALB—Platelet degranulation—VEGFC—sarcoma	0.000674	0.00552	CbGpPWpGaD
Estropipate—Anaphylactic shock—Etoposide—sarcoma	0.000669	0.00169	CcSEcCtD
Estropipate—Mood swings—Doxorubicin—sarcoma	0.000669	0.00169	CcSEcCtD
Estropipate—Asthenia—Thiotepa—sarcoma	0.000668	0.00169	CcSEcCtD
Estropipate—Infection—Etoposide—sarcoma	0.000665	0.00168	CcSEcCtD
Estropipate—Abdominal distension—Epirubicin—sarcoma	0.000664	0.00168	CcSEcCtD
Estropipate—Asthenia—Dactinomycin—sarcoma	0.000663	0.00168	CcSEcCtD
Estropipate—Asthma—Epirubicin—sarcoma	0.00066	0.00167	CcSEcCtD
Estropipate—Influenza—Epirubicin—sarcoma	0.00066	0.00167	CcSEcCtD
Estropipate—Pruritus—Thiotepa—sarcoma	0.000659	0.00167	CcSEcCtD
Estropipate—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000658	0.00166	CcSEcCtD
Estropipate—ESR1—Leptin signaling pathway—FOXO1—sarcoma	0.000656	0.00537	CbGpPWpGaD
Estropipate—Abdominal pain—Vincristine—sarcoma	0.000653	0.00165	CcSEcCtD
Estropipate—Body temperature increased—Vincristine—sarcoma	0.000653	0.00165	CcSEcCtD
Estropipate—Skin disorder—Etoposide—sarcoma	0.00065	0.00164	CcSEcCtD
Estropipate—Pancreatitis—Epirubicin—sarcoma	0.000647	0.00164	CcSEcCtD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFC—sarcoma	0.000643	0.00526	CbGpPWpGaD
Estropipate—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000641	0.00524	CbGpPWpGaD
Estropipate—Urticaria—Mitoxantrone—sarcoma	0.000639	0.00162	CcSEcCtD
Estropipate—Breast disorder—Doxorubicin—sarcoma	0.000638	0.00161	CcSEcCtD
Estropipate—Diarrhoea—Thiotepa—sarcoma	0.000637	0.00161	CcSEcCtD
Estropipate—Abdominal pain—Mitoxantrone—sarcoma	0.000636	0.00161	CcSEcCtD
Estropipate—Body temperature increased—Mitoxantrone—sarcoma	0.000636	0.00161	CcSEcCtD
Estropipate—Diarrhoea—Dactinomycin—sarcoma	0.000633	0.0016	CcSEcCtD
Estropipate—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—sarcoma	0.000629	0.00515	CbGpPWpGaD
Estropipate—ESR2—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	0.000619	0.00507	CbGpPWpGaD
Estropipate—Dysuria—Epirubicin—sarcoma	0.000617	0.00156	CcSEcCtD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—FOXO1—sarcoma	0.000617	0.00505	CbGpPWpGaD
Estropipate—Dizziness—Thiotepa—sarcoma	0.000616	0.00156	CcSEcCtD
Estropipate—Abdominal distension—Doxorubicin—sarcoma	0.000614	0.00155	CcSEcCtD
Estropipate—Upper respiratory tract infection—Epirubicin—sarcoma	0.000613	0.00155	CcSEcCtD
Estropipate—Influenza—Doxorubicin—sarcoma	0.00061	0.00154	CcSEcCtD
Estropipate—Asthma—Doxorubicin—sarcoma	0.00061	0.00154	CcSEcCtD
Estropipate—Hypersensitivity—Vincristine—sarcoma	0.000609	0.00154	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000605	0.00495	CbGpPWpGaD
Estropipate—Paraesthesia—Etoposide—sarcoma	0.000601	0.00152	CcSEcCtD
Estropipate—Weight increased—Epirubicin—sarcoma	0.0006	0.00152	CcSEcCtD
Estropipate—Pancreatitis—Doxorubicin—sarcoma	0.000598	0.00151	CcSEcCtD
Estropipate—Hyperglycaemia—Epirubicin—sarcoma	0.000595	0.0015	CcSEcCtD
Estropipate—Somnolence—Etoposide—sarcoma	0.000595	0.0015	CcSEcCtD
Estropipate—Hypersensitivity—Mitoxantrone—sarcoma	0.000593	0.0015	CcSEcCtD
Estropipate—Asthenia—Vincristine—sarcoma	0.000593	0.0015	CcSEcCtD
Estropipate—CYP1A2—Melatonin metabolism and effects—FOXO1—sarcoma	0.000592	0.00485	CbGpPWpGaD
Estropipate—Vomiting—Thiotepa—sarcoma	0.000592	0.0015	CcSEcCtD
Estropipate—Infestation NOS—Epirubicin—sarcoma	0.000588	0.00149	CcSEcCtD
Estropipate—Infestation—Epirubicin—sarcoma	0.000588	0.00149	CcSEcCtD
Estropipate—Vomiting—Dactinomycin—sarcoma	0.000588	0.00149	CcSEcCtD
Estropipate—Rash—Thiotepa—sarcoma	0.000587	0.00149	CcSEcCtD
Estropipate—CYP1A2—Estrogen Receptor Pathway—JUN—sarcoma	0.000587	0.0048	CbGpPWpGaD
Estropipate—Dermatitis—Thiotepa—sarcoma	0.000587	0.00148	CcSEcCtD
Estropipate—Headache—Thiotepa—sarcoma	0.000584	0.00148	CcSEcCtD
Estropipate—Rash—Dactinomycin—sarcoma	0.000583	0.00147	CcSEcCtD
Estropipate—Gastrointestinal disorder—Etoposide—sarcoma	0.000578	0.00146	CcSEcCtD
Estropipate—Asthenia—Mitoxantrone—sarcoma	0.000577	0.00146	CcSEcCtD
Estropipate—Fatigue—Etoposide—sarcoma	0.000577	0.00146	CcSEcCtD
Estropipate—Neuropathy peripheral—Epirubicin—sarcoma	0.000576	0.00146	CcSEcCtD
Estropipate—ESR1—ATF-2 transcription factor network—CREB1—sarcoma	0.000576	0.00472	CbGpPWpGaD
Estropipate—CYP3A4—liver—sarcoma	0.000576	0.00622	CbGeAlD
Estropipate—ALB—Selenium Micronutrient Network—HBA1—sarcoma	0.000575	0.00471	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000575	0.00471	CbGpPWpGaD
Estropipate—Constipation—Etoposide—sarcoma	0.000572	0.00145	CcSEcCtD
Estropipate—Pain—Etoposide—sarcoma	0.000572	0.00145	CcSEcCtD
Estropipate—Dysuria—Doxorubicin—sarcoma	0.000571	0.00144	CcSEcCtD
Estropipate—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000567	0.00143	CcSEcCtD
Estropipate—Diarrhoea—Vincristine—sarcoma	0.000565	0.00143	CcSEcCtD
Estropipate—Hepatobiliary disease—Epirubicin—sarcoma	0.000556	0.00141	CcSEcCtD
Estropipate—Weight increased—Doxorubicin—sarcoma	0.000555	0.0014	CcSEcCtD
Estropipate—Nausea—Thiotepa—sarcoma	0.000553	0.0014	CcSEcCtD
Estropipate—Sinusitis—Epirubicin—sarcoma	0.000552	0.0014	CcSEcCtD
Estropipate—Hyperglycaemia—Doxorubicin—sarcoma	0.000551	0.00139	CcSEcCtD
Estropipate—Diarrhoea—Mitoxantrone—sarcoma	0.00055	0.00139	CcSEcCtD
Estropipate—Nausea—Dactinomycin—sarcoma	0.000549	0.00139	CcSEcCtD
Estropipate—Gastrointestinal pain—Etoposide—sarcoma	0.000547	0.00138	CcSEcCtD
Estropipate—Dizziness—Vincristine—sarcoma	0.000546	0.00138	CcSEcCtD
Estropipate—ESR1—FOXM1 transcription factor network—CCND1—sarcoma	0.000545	0.00446	CbGpPWpGaD
Estropipate—Infestation—Doxorubicin—sarcoma	0.000544	0.00138	CcSEcCtD
Estropipate—Infestation NOS—Doxorubicin—sarcoma	0.000544	0.00138	CcSEcCtD
Estropipate—ESR1—ATF-2 transcription factor network—MMP2—sarcoma	0.000536	0.00439	CbGpPWpGaD
Estropipate—Neuropathy peripheral—Doxorubicin—sarcoma	0.000533	0.00135	CcSEcCtD
Estropipate—Urticaria—Etoposide—sarcoma	0.000532	0.00134	CcSEcCtD
Estropipate—Rhinitis—Epirubicin—sarcoma	0.000529	0.00134	CcSEcCtD
Estropipate—Abdominal pain—Etoposide—sarcoma	0.000529	0.00134	CcSEcCtD
Estropipate—Body temperature increased—Etoposide—sarcoma	0.000529	0.00134	CcSEcCtD
Estropipate—Vomiting—Vincristine—sarcoma	0.000525	0.00133	CcSEcCtD
Estropipate—ESR2—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000525	0.0043	CbGpPWpGaD
Estropipate—ESR1—FOXA1 transcription factor network—JUN—sarcoma	0.000524	0.00429	CbGpPWpGaD
Estropipate—Pharyngitis—Epirubicin—sarcoma	0.000524	0.00133	CcSEcCtD
Estropipate—Rash—Vincristine—sarcoma	0.000521	0.00132	CcSEcCtD
Estropipate—Dermatitis—Vincristine—sarcoma	0.00052	0.00132	CcSEcCtD
Estropipate—Oedema peripheral—Epirubicin—sarcoma	0.00052	0.00132	CcSEcCtD
Estropipate—Headache—Vincristine—sarcoma	0.000517	0.00131	CcSEcCtD
Estropipate—Hepatobiliary disease—Doxorubicin—sarcoma	0.000515	0.0013	CcSEcCtD
Estropipate—Vomiting—Mitoxantrone—sarcoma	0.000511	0.00129	CcSEcCtD
Estropipate—Sinusitis—Doxorubicin—sarcoma	0.000511	0.00129	CcSEcCtD
Estropipate—Visual impairment—Epirubicin—sarcoma	0.000509	0.00129	CcSEcCtD
Estropipate—Rash—Mitoxantrone—sarcoma	0.000507	0.00128	CcSEcCtD
Estropipate—Dermatitis—Mitoxantrone—sarcoma	0.000507	0.00128	CcSEcCtD
Estropipate—Headache—Mitoxantrone—sarcoma	0.000504	0.00127	CcSEcCtD
Estropipate—ESR1—AP-1 transcription factor network—CREB1—sarcoma	0.000503	0.00411	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—ATF1—sarcoma	0.000502	0.00411	CbGpPWpGaD
Estropipate—Erythema multiforme—Epirubicin—sarcoma	0.000499	0.00126	CcSEcCtD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—SRC—sarcoma	0.000497	0.00407	CbGpPWpGaD
Estropipate—Eye disorder—Epirubicin—sarcoma	0.000493	0.00125	CcSEcCtD
Estropipate—Hypersensitivity—Etoposide—sarcoma	0.000493	0.00125	CcSEcCtD
Estropipate—Nausea—Vincristine—sarcoma	0.000491	0.00124	CcSEcCtD
Estropipate—Cardiac disorder—Epirubicin—sarcoma	0.00049	0.00124	CcSEcCtD
Estropipate—Rhinitis—Doxorubicin—sarcoma	0.00049	0.00124	CcSEcCtD
Estropipate—Pharyngitis—Doxorubicin—sarcoma	0.000485	0.00123	CcSEcCtD
Estropipate—Oedema peripheral—Doxorubicin—sarcoma	0.000481	0.00122	CcSEcCtD
Estropipate—Asthenia—Etoposide—sarcoma	0.00048	0.00121	CcSEcCtD
Estropipate—Angiopathy—Epirubicin—sarcoma	0.000479	0.00121	CcSEcCtD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—NRAS—sarcoma	0.000479	0.00392	CbGpPWpGaD
Estropipate—Nausea—Mitoxantrone—sarcoma	0.000478	0.00121	CcSEcCtD
Estropipate—Immune system disorder—Epirubicin—sarcoma	0.000477	0.00121	CcSEcCtD
Estropipate—Mediastinal disorder—Epirubicin—sarcoma	0.000476	0.0012	CcSEcCtD
Estropipate—ESR1—Leptin signaling pathway—CREB1—sarcoma	0.000476	0.00389	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—FUS—sarcoma	0.000475	0.00389	CbGpPWpGaD
Estropipate—Pruritus—Etoposide—sarcoma	0.000473	0.0012	CcSEcCtD
Estropipate—Visual impairment—Doxorubicin—sarcoma	0.000471	0.00119	CcSEcCtD
Estropipate—Alopecia—Epirubicin—sarcoma	0.000467	0.00118	CcSEcCtD
Estropipate—Mental disorder—Epirubicin—sarcoma	0.000463	0.00117	CcSEcCtD
Estropipate—Erythema multiforme—Doxorubicin—sarcoma	0.000462	0.00117	CcSEcCtD
Estropipate—Malnutrition—Epirubicin—sarcoma	0.00046	0.00116	CcSEcCtD
Estropipate—Erythema—Epirubicin—sarcoma	0.00046	0.00116	CcSEcCtD
Estropipate—Diarrhoea—Etoposide—sarcoma	0.000458	0.00116	CcSEcCtD
Estropipate—Eye disorder—Doxorubicin—sarcoma	0.000457	0.00115	CcSEcCtD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—SRC—sarcoma	0.000454	0.00371	CbGpPWpGaD
Estropipate—Cardiac disorder—Doxorubicin—sarcoma	0.000453	0.00115	CcSEcCtD
Estropipate—Flatulence—Epirubicin—sarcoma	0.000453	0.00115	CcSEcCtD
Estropipate—Tension—Epirubicin—sarcoma	0.000451	0.00114	CcSEcCtD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—CREB1—sarcoma	0.000447	0.00366	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000447	0.00365	CbGpPWpGaD
Estropipate—Nervousness—Epirubicin—sarcoma	0.000446	0.00113	CcSEcCtD
Estropipate—Back pain—Epirubicin—sarcoma	0.000445	0.00112	CcSEcCtD
Estropipate—Angiopathy—Doxorubicin—sarcoma	0.000443	0.00112	CcSEcCtD
Estropipate—Dizziness—Etoposide—sarcoma	0.000442	0.00112	CcSEcCtD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	0.000442	0.00362	CbGpPWpGaD
Estropipate—Muscle spasms—Epirubicin—sarcoma	0.000442	0.00112	CcSEcCtD
Estropipate—Immune system disorder—Doxorubicin—sarcoma	0.000441	0.00112	CcSEcCtD
Estropipate—Mediastinal disorder—Doxorubicin—sarcoma	0.00044	0.00111	CcSEcCtD
Estropipate—ALB—FOXA2 and FOXA3 transcription factor networks—CREB1—sarcoma	0.00044	0.0036	CbGpPWpGaD
Estropipate—ESR1—FOXM1 transcription factor network—MYC—sarcoma	0.000437	0.00358	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—NRAS—sarcoma	0.000436	0.00357	CbGpPWpGaD
Estropipate—Alopecia—Doxorubicin—sarcoma	0.000432	0.00109	CcSEcCtD
Estropipate—ESR1—LKB1 signaling events—MYC—sarcoma	0.000429	0.00351	CbGpPWpGaD
Estropipate—Mental disorder—Doxorubicin—sarcoma	0.000428	0.00108	CcSEcCtD
Estropipate—Vomiting—Etoposide—sarcoma	0.000425	0.00108	CcSEcCtD
Estropipate—Erythema—Doxorubicin—sarcoma	0.000425	0.00108	CcSEcCtD
Estropipate—Malnutrition—Doxorubicin—sarcoma	0.000425	0.00108	CcSEcCtD
Estropipate—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000423	0.00346	CbGpPWpGaD
Estropipate—Rash—Etoposide—sarcoma	0.000422	0.00107	CcSEcCtD
Estropipate—Dermatitis—Etoposide—sarcoma	0.000422	0.00107	CcSEcCtD
Estropipate—Headache—Etoposide—sarcoma	0.000419	0.00106	CcSEcCtD
Estropipate—Flatulence—Doxorubicin—sarcoma	0.000419	0.00106	CcSEcCtD
Estropipate—Tension—Doxorubicin—sarcoma	0.000417	0.00106	CcSEcCtD
Estropipate—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—sarcoma	0.000415	0.0034	CbGpPWpGaD
Estropipate—ESR1—ATF-2 transcription factor network—CCND1—sarcoma	0.000415	0.0034	CbGpPWpGaD
Estropipate—ESR1—ATF-2 transcription factor network—JUN—sarcoma	0.000414	0.00339	CbGpPWpGaD
Estropipate—Nervousness—Doxorubicin—sarcoma	0.000413	0.00104	CcSEcCtD
Estropipate—Vertigo—Epirubicin—sarcoma	0.000413	0.00104	CcSEcCtD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—KRAS—sarcoma	0.000412	0.00337	CbGpPWpGaD
Estropipate—Back pain—Doxorubicin—sarcoma	0.000411	0.00104	CcSEcCtD
Estropipate—Muscle spasms—Doxorubicin—sarcoma	0.000409	0.00103	CcSEcCtD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—MYC—sarcoma	0.000407	0.00333	CbGpPWpGaD
Estropipate—Palpitations—Epirubicin—sarcoma	0.000406	0.00103	CcSEcCtD
Estropipate—Cough—Epirubicin—sarcoma	0.000401	0.00101	CcSEcCtD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	0.000398	0.00325	CbGpPWpGaD
Estropipate—Nausea—Etoposide—sarcoma	0.000397	0.00101	CcSEcCtD
Estropipate—Arthralgia—Epirubicin—sarcoma	0.000391	0.00099	CcSEcCtD
Estropipate—Myalgia—Epirubicin—sarcoma	0.000391	0.00099	CcSEcCtD
Estropipate—Anxiety—Epirubicin—sarcoma	0.00039	0.000986	CcSEcCtD
Estropipate—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—sarcoma	0.000389	0.00318	CbGpPWpGaD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000389	0.000983	CcSEcCtD
Estropipate—ESR1—Validated nuclear estrogen receptor alpha network—JUN—sarcoma	0.000388	0.00318	CbGpPWpGaD
Estropipate—Vertigo—Doxorubicin—sarcoma	0.000382	0.000966	CcSEcCtD
Estropipate—ESR1—Regulation of Telomerase—IL2—sarcoma	0.00038	0.00311	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—JUN—sarcoma	0.000378	0.00309	CbGpPWpGaD
Estropipate—Palpitations—Doxorubicin—sarcoma	0.000376	0.00095	CcSEcCtD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	0.000376	0.00307	CbGpPWpGaD
Estropipate—Anaphylactic shock—Epirubicin—sarcoma	0.000375	0.000949	CcSEcCtD
Estropipate—Oedema—Epirubicin—sarcoma	0.000375	0.000949	CcSEcCtD
Estropipate—ESR2—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000375	0.00307	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—FOXO1—sarcoma	0.000375	0.00307	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—FOXO1—sarcoma	0.000373	0.00305	CbGpPWpGaD
Estropipate—Infection—Epirubicin—sarcoma	0.000373	0.000942	CcSEcCtD
Estropipate—ESR1—Signaling by ERBB4—PDGFRB—sarcoma	0.000372	0.00304	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—IL2—sarcoma	0.000372	0.00304	CbGpPWpGaD
Estropipate—Cough—Doxorubicin—sarcoma	0.000371	0.000939	CcSEcCtD
Estropipate—ESR1—Regulation of Telomerase—CCND1—sarcoma	0.000371	0.00303	CbGpPWpGaD
Estropipate—ESR1—Regulation of Telomerase—JUN—sarcoma	0.00037	0.00303	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000369	0.00302	CbGpPWpGaD
Estropipate—Nervous system disorder—Epirubicin—sarcoma	0.000368	0.00093	CcSEcCtD
Estropipate—ESR1—Signaling by ERBB4—PDGFRA—sarcoma	0.000366	0.003	CbGpPWpGaD
Estropipate—Skin disorder—Epirubicin—sarcoma	0.000364	0.000921	CcSEcCtD
Estropipate—ESR1—AP-1 transcription factor network—CCND1—sarcoma	0.000362	0.00296	CbGpPWpGaD
Estropipate—Arthralgia—Doxorubicin—sarcoma	0.000362	0.000916	CcSEcCtD
Estropipate—Myalgia—Doxorubicin—sarcoma	0.000362	0.000916	CcSEcCtD
Estropipate—ESR1—AP-1 transcription factor network—JUN—sarcoma	0.000361	0.00296	CbGpPWpGaD
Estropipate—Anxiety—Doxorubicin—sarcoma	0.000361	0.000913	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00036	0.000909	CcSEcCtD
Estropipate—ESR1—AP-1 transcription factor network—CTNNB1—sarcoma	0.000359	0.00294	CbGpPWpGaD
Estropipate—ESR1—LKB1 signaling events—TP53—sarcoma	0.000352	0.00288	CbGpPWpGaD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—HRAS—sarcoma	0.00035	0.00287	CbGpPWpGaD
Estropipate—Oedema—Doxorubicin—sarcoma	0.000347	0.000878	CcSEcCtD
Estropipate—Anaphylactic shock—Doxorubicin—sarcoma	0.000347	0.000878	CcSEcCtD
Estropipate—Infection—Doxorubicin—sarcoma	0.000345	0.000872	CcSEcCtD
Estropipate—ESR1—Leptin signaling pathway—CCND1—sarcoma	0.000343	0.00281	CbGpPWpGaD
Estropipate—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000342	0.000864	CcSEcCtD
Estropipate—Nervous system disorder—Doxorubicin—sarcoma	0.00034	0.000861	CcSEcCtD
Estropipate—Insomnia—Epirubicin—sarcoma	0.000339	0.000858	CcSEcCtD
Estropipate—Skin disorder—Doxorubicin—sarcoma	0.000337	0.000853	CcSEcCtD
Estropipate—Paraesthesia—Epirubicin—sarcoma	0.000337	0.000852	CcSEcCtD
Estropipate—Somnolence—Epirubicin—sarcoma	0.000333	0.000843	CcSEcCtD
Estropipate—Dyspepsia—Epirubicin—sarcoma	0.00033	0.000835	CcSEcCtD
Estropipate—ESR2—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.00033	0.0027	CbGpPWpGaD
Estropipate—Gastrointestinal disorder—Epirubicin—sarcoma	0.000324	0.000819	CcSEcCtD
Estropipate—Fatigue—Epirubicin—sarcoma	0.000323	0.000818	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000322	0.00263	CbGpPWpGaD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—sarcoma	0.000322	0.00263	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000321	0.00263	CbGpPWpGaD
Estropipate—Constipation—Epirubicin—sarcoma	0.000321	0.000811	CcSEcCtD
Estropipate—Pain—Epirubicin—sarcoma	0.000321	0.000811	CcSEcCtD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	0.000319	0.00261	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000319	0.00261	CbGpPWpGaD
Estropipate—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000316	0.0008	CcSEcCtD
Estropipate—Insomnia—Doxorubicin—sarcoma	0.000314	0.000794	CcSEcCtD
Estropipate—ESR1—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	0.000312	0.00255	CbGpPWpGaD
Estropipate—Paraesthesia—Doxorubicin—sarcoma	0.000312	0.000788	CcSEcCtD
Estropipate—Somnolence—Doxorubicin—sarcoma	0.000309	0.00078	CcSEcCtD
Estropipate—ESR1—Leptin signaling pathway—SRC—sarcoma	0.000307	0.00251	CbGpPWpGaD
Estropipate—Gastrointestinal pain—Epirubicin—sarcoma	0.000307	0.000776	CcSEcCtD
Estropipate—Dyspepsia—Doxorubicin—sarcoma	0.000305	0.000773	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000305	0.0025	CbGpPWpGaD
Estropipate—Gastrointestinal disorder—Doxorubicin—sarcoma	0.0003	0.000758	CcSEcCtD
Estropipate—Fatigue—Doxorubicin—sarcoma	0.000299	0.000757	CcSEcCtD
Estropipate—ALB—Platelet activation, signaling and aggregation—VEGFC—sarcoma	0.000299	0.00245	CbGpPWpGaD
Estropipate—Urticaria—Epirubicin—sarcoma	0.000298	0.000754	CcSEcCtD
Estropipate—ESR1—Regulation of Telomerase—MYC—sarcoma	0.000297	0.00243	CbGpPWpGaD
Estropipate—Pain—Doxorubicin—sarcoma	0.000297	0.000751	CcSEcCtD
Estropipate—Constipation—Doxorubicin—sarcoma	0.000297	0.000751	CcSEcCtD
Estropipate—Body temperature increased—Epirubicin—sarcoma	0.000297	0.00075	CcSEcCtD
Estropipate—Abdominal pain—Epirubicin—sarcoma	0.000297	0.00075	CcSEcCtD
Estropipate—ESR1—Regulation of Telomerase—EGFR—sarcoma	0.000291	0.00238	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—MYC—sarcoma	0.000291	0.00238	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000288	0.00236	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—KIT—sarcoma	0.000284	0.00232	CbGpPWpGaD
Estropipate—Gastrointestinal pain—Doxorubicin—sarcoma	0.000284	0.000718	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000281	0.0023	CbGpPWpGaD
Estropipate—Hypersensitivity—Epirubicin—sarcoma	0.000276	0.000699	CcSEcCtD
Estropipate—Urticaria—Doxorubicin—sarcoma	0.000276	0.000697	CcSEcCtD
Estropipate—Body temperature increased—Doxorubicin—sarcoma	0.000274	0.000694	CcSEcCtD
Estropipate—Abdominal pain—Doxorubicin—sarcoma	0.000274	0.000694	CcSEcCtD
Estropipate—ESR1—Integrated Breast Cancer Pathway—CREB1—sarcoma	0.000272	0.00222	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—CREB1—sarcoma	0.00027	0.00221	CbGpPWpGaD
Estropipate—Asthenia—Epirubicin—sarcoma	0.000269	0.000681	CcSEcCtD
Estropipate—Pruritus—Epirubicin—sarcoma	0.000265	0.000671	CcSEcCtD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	0.000259	0.00212	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000258	0.00211	CbGpPWpGaD
Estropipate—Diarrhoea—Epirubicin—sarcoma	0.000257	0.000649	CcSEcCtD
Estropipate—Hypersensitivity—Doxorubicin—sarcoma	0.000256	0.000647	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000252	0.00207	CbGpPWpGaD
Estropipate—Asthenia—Doxorubicin—sarcoma	0.000249	0.00063	CcSEcCtD
Estropipate—Dizziness—Epirubicin—sarcoma	0.000248	0.000627	CcSEcCtD
Estropipate—CYP1A2—Tryptophan metabolism—MDM2—sarcoma	0.000246	0.00201	CbGpPWpGaD
Estropipate—Pruritus—Doxorubicin—sarcoma	0.000246	0.000621	CcSEcCtD
Estropipate—ESR1—Gene Expression—FUS—sarcoma	0.000239	0.00196	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—TP53—sarcoma	0.000239	0.00195	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000239	0.00195	CbGpPWpGaD
Estropipate—Vomiting—Epirubicin—sarcoma	0.000238	0.000603	CcSEcCtD
Estropipate—Diarrhoea—Doxorubicin—sarcoma	0.000237	0.000601	CcSEcCtD
Estropipate—Rash—Epirubicin—sarcoma	0.000236	0.000598	CcSEcCtD
Estropipate—Dermatitis—Epirubicin—sarcoma	0.000236	0.000598	CcSEcCtD
Estropipate—ALB—Folate Metabolism—IL2—sarcoma	0.000235	0.00192	CbGpPWpGaD
Estropipate—Headache—Epirubicin—sarcoma	0.000235	0.000594	CcSEcCtD
Estropipate—Dizziness—Doxorubicin—sarcoma	0.000229	0.00058	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000225	0.00184	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—MDM2—sarcoma	0.000225	0.00184	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—MDM2—sarcoma	0.000224	0.00183	CbGpPWpGaD
Estropipate—Nausea—Epirubicin—sarcoma	0.000223	0.000564	CcSEcCtD
Estropipate—Vomiting—Doxorubicin—sarcoma	0.000221	0.000558	CcSEcCtD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	0.00022	0.0018	CbGpPWpGaD
Estropipate—Rash—Doxorubicin—sarcoma	0.000219	0.000553	CcSEcCtD
Estropipate—Dermatitis—Doxorubicin—sarcoma	0.000219	0.000553	CcSEcCtD
Estropipate—Headache—Doxorubicin—sarcoma	0.000217	0.00055	CcSEcCtD
Estropipate—ESR1—Leptin signaling pathway—HRAS—sarcoma	0.000216	0.00177	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	0.000214	0.00175	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.000212	0.00173	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TEK—sarcoma	0.00021	0.00172	CbGpPWpGaD
Estropipate—Nausea—Doxorubicin—sarcoma	0.000206	0.000521	CcSEcCtD
Estropipate—SLC22A1—Transmission across Chemical Synapses—CREB1—sarcoma	0.000196	0.0016	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—CCND1—sarcoma	0.000196	0.0016	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—JUN—sarcoma	0.000195	0.0016	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	0.000194	0.00159	CbGpPWpGaD
Estropipate—ALB—Hemostasis—ANGPT2—sarcoma	0.000192	0.00157	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	0.000192	0.00157	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—SRC—sarcoma	0.000192	0.00157	CbGpPWpGaD
Estropipate—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	0.00019	0.00155	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	0.000187	0.00153	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000186	0.00152	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	0.000184	0.00151	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—MYC—sarcoma	0.000172	0.00141	CbGpPWpGaD
Estropipate—ALB—Platelet degranulation—VEGFA—sarcoma	0.000171	0.0014	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	0.000171	0.0014	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	0.000168	0.00137	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	0.000168	0.00137	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—NRAS—sarcoma	0.000168	0.00137	CbGpPWpGaD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	0.000163	0.00134	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000162	0.00133	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—MDM2—sarcoma	0.000162	0.00133	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000162	0.00133	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000161	0.00132	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	0.000159	0.0013	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—MYC—sarcoma	0.000157	0.00129	CbGpPWpGaD
Estropipate—ALB—Hemostasis—VEGFC—sarcoma	0.000154	0.00126	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—EGFR—sarcoma	0.000154	0.00126	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—EGFR—sarcoma	0.000153	0.00125	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—TP53—sarcoma	0.000151	0.00124	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—CREB1—sarcoma	0.00015	0.00123	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000145	0.00119	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—KRAS—sarcoma	0.000145	0.00119	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—KRAS—sarcoma	0.000144	0.00118	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000141	0.00116	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	0.000135	0.0011	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.00013	0.00107	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—TP53—sarcoma	0.000129	0.00106	CbGpPWpGaD
Estropipate—ESR2—Generic Transcription Pathway—MYC—sarcoma	0.000128	0.00105	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000127	0.00104	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—MDM2—sarcoma	0.000124	0.00102	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—HRAS—sarcoma	0.000123	0.001	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PLCG1—sarcoma	0.000121	0.000992	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.00012	0.000984	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.000107	0.000875	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TLE1—sarcoma	0.000103	0.00084	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—IL2—sarcoma	8.94e-05	0.000732	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—HRAS—sarcoma	8.89e-05	0.000728	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—VEGFC—sarcoma	8.66e-05	0.000709	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ENO2—sarcoma	8.66e-05	0.000708	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—HBA1—sarcoma	8.6e-05	0.000704	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—SRC—sarcoma	7.8e-05	0.000639	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—VEGFA—sarcoma	7.6e-05	0.000622	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PLCG1—sarcoma	7.34e-05	0.000601	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—FLT1—sarcoma	6.92e-05	0.000566	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—HRAS—sarcoma	6.81e-05	0.000558	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PLCG1—sarcoma	6.8e-05	0.000557	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CXCR4—sarcoma	6.54e-05	0.000535	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—MYC—sarcoma	6.47e-05	0.000529	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ATF1—sarcoma	6.46e-05	0.000529	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—MYC—sarcoma	6.17e-05	0.000505	CbGpPWpGaD
Estropipate—ALB—Metabolism—ENO2—sarcoma	5.79e-05	0.000474	CbGpPWpGaD
Estropipate—ALB—Metabolism—HBA1—sarcoma	5.75e-05	0.000471	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IGF1R—sarcoma	5.07e-05	0.000415	CbGpPWpGaD
Estropipate—ALB—Metabolism—PLCG1—sarcoma	4.91e-05	0.000402	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—FOXO1—sarcoma	4.83e-05	0.000395	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PDGFRB—sarcoma	4.82e-05	0.000394	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PDGFRA—sarcoma	4.74e-05	0.000388	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ENO2—sarcoma	4.74e-05	0.000388	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—HBA1—sarcoma	4.71e-05	0.000385	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IL2—sarcoma	4.61e-05	0.000377	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ENO2—sarcoma	4.05e-05	0.000331	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—HBA1—sarcoma	4.02e-05	0.000329	CbGpPWpGaD
Estropipate—ALB—Hemostasis—SRC—sarcoma	4.02e-05	0.000329	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PLCG1—sarcoma	4.02e-05	0.000329	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KDR—sarcoma	3.99e-05	0.000327	CbGpPWpGaD
Estropipate—ALB—Hemostasis—VEGFA—sarcoma	3.92e-05	0.000321	CbGpPWpGaD
Estropipate—ALB—Hemostasis—NRAS—sarcoma	3.87e-05	0.000317	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KIT—sarcoma	3.68e-05	0.000301	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CREB1—sarcoma	3.5e-05	0.000287	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PLCG1—sarcoma	3.44e-05	0.000281	CbGpPWpGaD
Estropipate—ALB—Hemostasis—KRAS—sarcoma	3.33e-05	0.000273	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ENO2—sarcoma	3.13e-05	0.000256	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—MYC—sarcoma	3.11e-05	0.000255	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—HBA1—sarcoma	3.11e-05	0.000254	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TP53—sarcoma	2.96e-05	0.000242	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MDM2—sarcoma	2.9e-05	0.000237	CbGpPWpGaD
Estropipate—ALB—Hemostasis—HRAS—sarcoma	2.83e-05	0.000232	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PLCG1—sarcoma	2.65e-05	0.000217	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL2—sarcoma	2.59e-05	0.000212	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCND1—sarcoma	2.52e-05	0.000207	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—JUN—sarcoma	2.52e-05	0.000206	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CTNNB1—sarcoma	2.5e-05	0.000205	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SRC—sarcoma	2.26e-05	0.000185	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—VEGFA—sarcoma	2.2e-05	0.00018	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NRAS—sarcoma	2.17e-05	0.000178	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MYC—sarcoma	2.02e-05	0.000166	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EGFR—sarcoma	1.98e-05	0.000162	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KRAS—sarcoma	1.87e-05	0.000153	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TP53—sarcoma	1.66e-05	0.000136	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HRAS—sarcoma	1.59e-05	0.00013	CbGpPWpGaD
